Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipoteichoic Acid Fraction from <i>Lactiplantibacillus plantarum</i> K8 Attenuates Inflammatory Responses and Promotes Antimicrobial Defense in Oral Epithelial Cells.

Microorganisms·2026
Same author

Culture supernatants from human-derived commensal bacteria alleviate DNCB-induced atopic dermatitis through modulation of inflammatory and barrier-associated pathways.

Frontiers in microbiology·2026
Same author

Hepatitis C virus E1 protein-specific linear B-cell epitopes, pan-genotype reactivity, and functional relevance.

Frontiers in immunology·2026
Same author

Neonatal and Pediatric Transport: A Contemporary Review.

Children (Basel, Switzerland)·2026
Same author

The Prevalence and Trend of Nontuberculous Mycobacterial Infection in Hospitalized Children in the United States From 2000 to 2022.

The Pediatric infectious disease journal·2025
Same author

Hepatic Effects, Potential Drug-Induced Liver Injury, and Other Liver Safety Considerations of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in the New Era of Expanding Non-oncology Indications: Literature Review and Expert Consensus.

Drug safety·2025

Related Experiment Video

Updated: May 13, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Hepatitis C virus suppresses C9 complement synthesis and impairs membrane attack complex function.

Hangeun Kim1, Keith Meyer, Adrian M Di Bisceglie

  • 1Department of Internal Medicine, Saint Louis University, St Louis, Missouri, USA.

Journal of Virology
|March 15, 2013
PubMed
Summary

Hepatitis C virus (HCV) inhibits complement component C9, weakening the immune system's membrane attack complex (MAC). This impairs the body's defense against pathogens during chronic HCV infection.

More Related Videos

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Related Experiment Videos

Last Updated: May 13, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Hepatitis C virus (HCV) infection can compromise the host immune response.
  • The complement system, particularly the membrane attack complex (MAC), is crucial for pathogen defense.
  • HCV's impact on complement component expression, specifically C9, was previously unclear.

Purpose of the Study:

  • To investigate how Hepatitis C virus (HCV) regulates the membrane attack complex (MAC) through complement component C9.
  • To determine the effect of HCV infection on C9 expression and MAC function in patients and cell models.

Main Methods:

  • Analysis of C9 mRNA levels in liver biopsy specimens from HCV-infected patients and controls.
  • Assessment of C9 mRNA and protein expression in HCV-infected hepatocytes and those expressing HCV core protein.
  • Promoter analysis to identify transcription factors involved in HCV core-mediated C9 regulation.
  • Measurement of C5b-9 levels and antimicrobial activity in sera from HCV-infected patients.

Main Results:

  • Lower C9 mRNA expression was observed in liver tissues of chronically HCV-infected patients compared to controls.
  • HCV infection and HCV core protein expression significantly repressed C9 mRNA and protein levels in hepatocytes.
  • T cell factor-4 (TCF-4E) was identified as a key transcription factor in HCV core-mediated C9 promoter regulation.
  • Sera from HCV-infected patients showed reduced C5b-9 levels and diminished antimicrobial efficacy.

Conclusions:

  • Hepatitis C virus core protein downregulates complement component C9 expression.
  • HCV-mediated C9 repression leads to functional impairment of the membrane attack complex (MAC).
  • These findings highlight a mechanism of immune evasion by HCV through attenuation of the innate immune system.